Lixian B. Wu

Fujian Key Laboratory Of Natural Medicine Pharmacology
Fuzhou, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications

Flavokawain A Targets CXCR4-Mediated Vasculogenic Mimicry to Reverse Hepatocellular Carcinoma Resistance to Tyrosine Kinase Inhibitors.

Flavokawain A Targets CXCR4-Mediated Vasculogenic Mimicry to Reverse Hepatocellular Carcinoma Resistance to Tyrosine Kinase Inhibitors.

Journal: Phytotherapy research : PTR
Published: August 14, 2025

Perceived knowledge and attitude towards blended learning in pharmacology among medical students.

Perceived knowledge and attitude towards blended learning in pharmacology among medical students.

Journal: Scientific reports
Published: July 02, 2025

Association between exposure to non-optimal temperature during pregnancy and preterm birth

Association between exposure to non-optimal temperature during pregnancy and preterm birth

Journal: Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi
Published: June 10, 2025

Modulating NPC1L1 to Potentiate PARP Inhibitor-Induced Ferroptosis and Immune Response in Triple-Negative Breast Cancer.

Modulating NPC1L1 to Potentiate PARP Inhibitor-Induced Ferroptosis and Immune Response in Triple-Negative Breast Cancer.

Journal: Pharmaceutics
Published: February 17, 2025

The Molecular Chaperone TCP1 Affects Carcinogenicity and Is a Potential Therapeutic Target for Acute Myeloid Leukemia.

The Molecular Chaperone TCP1 Affects Carcinogenicity and Is a Potential Therapeutic Target for Acute Myeloid Leukemia.

Journal: Pharmaceutics
Published: February 13, 2025

Ferroptosis boosted oral cancer photodynamic therapy by carrier-free Sorafenib-Ce6 self-assembly nanoparticles.

Ferroptosis boosted oral cancer photodynamic therapy by carrier-free Sorafenib-Ce6 self-assembly nanoparticles.

Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: November 17, 2023

Amiloride reduces fructosamine-3-kinase expression to restore sunitinib sensitivity in renal cell carcinoma.

Amiloride reduces fructosamine-3-kinase expression to restore sunitinib sensitivity in renal cell carcinoma.

Journal: iScience
Published: October 09, 2023

Albumin-encapsulated HSP90-PROTAC BP3 nanoparticles not only retain protein degradation ability but also enhance the antitumour activity of BP3 in vivo.

Albumin-encapsulated HSP90-PROTAC BP3 nanoparticles not only retain protein degradation ability but also enhance the antitumour activity of BP3 in vivo.

Journal: Journal of drug targeting
Published: March 03, 2023

Synthesis of novel dual target inhibitors of PARP and EGFR and their antitumor activities in triple negative breast cancers.

Synthesis of novel dual target inhibitors of PARP and EGFR and their antitumor activities in triple negative breast cancers.

Journal: Bioorganic & medicinal chemistry
Published: March 01, 2022

MiR-519d-5p modulates the sensitivity of breast cancer to chemotherapy by forming a negative feedback loop with RELA.

MiR-519d-5p modulates the sensitivity of breast cancer to chemotherapy by forming a negative feedback loop with RELA.

Journal: Annals of translational medicine
Published: June 04, 2021

FM0807 decelerates experimental arthritis progression by inhibiting inflammatory responses and joint destruction via modulating NF-κB and MAPK pathways.

FM0807 decelerates experimental arthritis progression by inhibiting inflammatory responses and joint destruction via modulating NF-κB and MAPK pathways.

Journal: Bioscience reports
Published: December 04, 2018

Effects of FM0807, a novel curcumin derivative, on lipopolysaccharide-induced inflammatory factor release via the ROS/JNK/p53 pathway in RAW264.7 cells.

Effects of FM0807, a novel curcumin derivative, on lipopolysaccharide-induced inflammatory factor release via the ROS/JNK/p53 pathway in RAW264.7 cells.

Journal: Bioscience reports
Published: May 28, 2018
Showing 1-12 of 18

Last Updated: 09/26/2026